Posted by Michael Wonder on 28 Feb 2023
PHARMAC will fund meningococcal B vaccine for babies, teens and young people
28 February 2023 - From Wendesday, PHARMAC will fund meningococcal B vaccine for a number of potentially at-risk groups including babies, teens and young people.
The vaccine, branded as Bexsero, will be funded for children up to 12 months of age, with a catch-up programme for children aged 13 months to five years, until 31 August 2025.
